Cargando…
Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia
Pneumonia is a common cause of morbidity and mortality and is most often caused by bacterial pathogens. COVID-19 is characterized by lung infection with potential progressive organ failure. The systemic consequences of both disease on the systemic blood metabolome are not fully understood. The aim o...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693035/ https://www.ncbi.nlm.nih.gov/pubmed/36355140 http://dx.doi.org/10.3390/metabo12111058 |
_version_ | 1784837433504825344 |
---|---|
author | More, Tushar H. Mozafari, Bahareh Märtens, Andre Herr, Christian Lepper, Philipp M. Danziger, Guy Volk, Thomas Hoersch, Sabrina Krawczyk, Marcin Guenther, Katharina Hiller, Karsten Bals, Robert |
author_facet | More, Tushar H. Mozafari, Bahareh Märtens, Andre Herr, Christian Lepper, Philipp M. Danziger, Guy Volk, Thomas Hoersch, Sabrina Krawczyk, Marcin Guenther, Katharina Hiller, Karsten Bals, Robert |
author_sort | More, Tushar H. |
collection | PubMed |
description | Pneumonia is a common cause of morbidity and mortality and is most often caused by bacterial pathogens. COVID-19 is characterized by lung infection with potential progressive organ failure. The systemic consequences of both disease on the systemic blood metabolome are not fully understood. The aim of this study was to compare the blood metabolome of both diseases and we hypothesize that plasma metabolomics may help to identify the systemic effects of these diseases. Therefore, we profiled the plasma metabolome of 43 cases of COVID-19 pneumonia, 23 cases of non-COVID-19 pneumonia, and 26 controls using a non-targeted approach. Metabolic alterations differentiating the three groups were detected, with specific metabolic changes distinguishing the two types of pneumonia groups. A comparison of venous and arterial blood plasma samples from the same subjects revealed the distinct metabolic effects of pulmonary pneumonia. In addition, a machine learning signature of four metabolites was predictive of the disease outcome of COVID-19 subjects with an area under the curve (AUC) of 86 ± 10%. Overall, the results of this study uncover systemic metabolic changes that could be linked to the etiology of COVID-19 pneumonia and non-COVID-19 pneumonia. |
format | Online Article Text |
id | pubmed-9693035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96930352022-11-26 Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia More, Tushar H. Mozafari, Bahareh Märtens, Andre Herr, Christian Lepper, Philipp M. Danziger, Guy Volk, Thomas Hoersch, Sabrina Krawczyk, Marcin Guenther, Katharina Hiller, Karsten Bals, Robert Metabolites Article Pneumonia is a common cause of morbidity and mortality and is most often caused by bacterial pathogens. COVID-19 is characterized by lung infection with potential progressive organ failure. The systemic consequences of both disease on the systemic blood metabolome are not fully understood. The aim of this study was to compare the blood metabolome of both diseases and we hypothesize that plasma metabolomics may help to identify the systemic effects of these diseases. Therefore, we profiled the plasma metabolome of 43 cases of COVID-19 pneumonia, 23 cases of non-COVID-19 pneumonia, and 26 controls using a non-targeted approach. Metabolic alterations differentiating the three groups were detected, with specific metabolic changes distinguishing the two types of pneumonia groups. A comparison of venous and arterial blood plasma samples from the same subjects revealed the distinct metabolic effects of pulmonary pneumonia. In addition, a machine learning signature of four metabolites was predictive of the disease outcome of COVID-19 subjects with an area under the curve (AUC) of 86 ± 10%. Overall, the results of this study uncover systemic metabolic changes that could be linked to the etiology of COVID-19 pneumonia and non-COVID-19 pneumonia. MDPI 2022-11-02 /pmc/articles/PMC9693035/ /pubmed/36355140 http://dx.doi.org/10.3390/metabo12111058 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article More, Tushar H. Mozafari, Bahareh Märtens, Andre Herr, Christian Lepper, Philipp M. Danziger, Guy Volk, Thomas Hoersch, Sabrina Krawczyk, Marcin Guenther, Katharina Hiller, Karsten Bals, Robert Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia |
title | Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia |
title_full | Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia |
title_fullStr | Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia |
title_full_unstemmed | Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia |
title_short | Plasma Metabolome Alterations Discriminate between COVID-19 and Non-COVID-19 Pneumonia |
title_sort | plasma metabolome alterations discriminate between covid-19 and non-covid-19 pneumonia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693035/ https://www.ncbi.nlm.nih.gov/pubmed/36355140 http://dx.doi.org/10.3390/metabo12111058 |
work_keys_str_mv | AT moretusharh plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT mozafaribahareh plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT martensandre plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT herrchristian plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT lepperphilippm plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT danzigerguy plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT volkthomas plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT hoerschsabrina plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT krawczykmarcin plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT guentherkatharina plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT hillerkarsten plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia AT balsrobert plasmametabolomealterationsdiscriminatebetweencovid19andnoncovid19pneumonia |